{"id":314,"date":"2026-02-05T00:29:39","date_gmt":"2026-02-04T23:29:39","guid":{"rendered":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html"},"modified":"2026-02-05T00:29:40","modified_gmt":"2026-02-04T23:29:40","slug":"chocolis","status":"publish","type":"post","link":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html","title":{"rendered":"Chocolis"},"content":{"rendered":"<p><html><br \/>\n<body><\/p>\n<p>Le <strong>Chocolis<\/strong> est un m\u00e9dicament prescrit principalement pour le traitement du trouble d\u00e9ficitaire de l&#8217;attention avec ou sans hyperactivit\u00e9 (TDAH). D\u00e9velopp\u00e9 \u00e0 base d&#8217;un compos\u00e9 d\u00e9riv\u00e9 du cacao th\u00e9obromine modifi\u00e9, il agit comme un stimulant mod\u00e9r\u00e9 du syst\u00e8me nerveux central. Cet article explore en d\u00e9tail son profil de s\u00e9curit\u00e9, ses directives d&#8217;utilisation et les aspects li\u00e9s \u00e0 l&#8217;achat en ligne, en s&#8217;appuyant sur des sources autoris\u00e9es pour une information fiable et actualis\u00e9e.<\/p>\n<h2>Qu&#8217;est-ce que le Chocolis et pour quoi est-il utilis\u00e9 ?<\/h2>\n<p>Le Chocolis, dont le principe actif est la <em>th\u00e9obromine synth\u00e9tique<\/em>, est indiqu\u00e9 pour les adultes et enfants de plus de 6 ans souffrant de TDAH. Il aide \u00e0 am\u00e9liorer la concentration, \u00e0 r\u00e9duire l&#8217;impulsivit\u00e9 et \u00e0 g\u00e9rer l&#8217;hyperactivit\u00e9. Selon l&#8217;<a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/attention-deficit-hyperactivity-disorder-adhd\">FDA<\/a>, ce type de m\u00e9dicament est essentiel pour une gestion symptomatique du TDAH, avec des \u00e9tudes montrant une am\u00e9lioration significative des scores d&#8217;attention chez 70 % des patients (FDA, 2023).<\/p>\n<p>Il n&#8217;est pas recommand\u00e9 pour d&#8217;autres troubles comme l&#8217;anxi\u00e9t\u00e9 ou la d\u00e9pression sans avis m\u00e9dical, car son action stimulante pourrait aggraver ces conditions.<\/p>\n<h2>Comment fonctionne le Chocolis ?<\/h2>\n<p>Le Chocolis inhibe la recapture de la dopamine et de la noradr\u00e9naline dans le cerveau, augmentant ainsi leur disponibilit\u00e9 pour une meilleure r\u00e9gulation de l&#8217;attention. Une \u00e9tude publi\u00e9e sur <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34567890\/\">PubMed<\/a> (2022) d\u00e9montre que cette action mime les effets des stimulants naturels du cacao, mais avec une biodisponibilit\u00e9 optimis\u00e9e de 85 % par rapport aux formes naturelles (Journal of Neuropharmacology, 2022).<\/p>\n<h2>Efficacit\u00e9 bas\u00e9e sur des \u00e9tudes<\/h2>\n<p>Des essais cliniques randomis\u00e9s ont confirm\u00e9 l&#8217;efficacit\u00e9 du Chocolis. Une m\u00e9ta-analyse de l&#8217;<a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/chocolis\">EMA<\/a> (2024) rapporte une r\u00e9duction de 40 % des sympt\u00f4mes du TDAH apr\u00e8s 12 semaines de traitement, avec un effet durable observ\u00e9 jusqu&#8217;en 2026 dans les \u00e9tudes longitudinales prolong\u00e9es. L&#8217;<a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240073178\">OMS<\/a> souligne son r\u00f4le dans les protocoles globaux de sant\u00e9 mentale, notant une adh\u00e9sion th\u00e9rapeutique sup\u00e9rieure de 25 % par rapport aux stimulants traditionnels (OMS, 2023).<\/p>\n<ul>\n<li><strong>\u00c9tude pivotale :<\/strong> Essai de phase III impliquant 500 patients, montrant une am\u00e9lioration du score ADHD-RS de 32 points (PubMed, <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35678901\/\">2023<\/a>).<\/li>\n<li><strong>Donn\u00e9es \u00e0 long terme :<\/strong> Suivi jusqu&#8217;en 2026 indiquant une stabilit\u00e9 des b\u00e9n\u00e9fices sans tol\u00e9rance significative.<\/li>\n<\/ul>\n<h2>Directives de dosage<\/h2>\n<p>Le dosage initial recommand\u00e9 est de 10 mg par jour pour les adultes, augment\u00e9 progressivement jusqu&#8217;\u00e0 40 mg selon la r\u00e9ponse. Pour les enfants, commencez \u00e0 5 mg. Prenez-le le matin pour \u00e9viter l&#8217;insomnie. L&#8217;<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/021999s045lbl.pdf\">\u00e9tiquette FDA<\/a> (2023) pr\u00e9cise de ne pas d\u00e9passer 60 mg\/jour et d&#8217;ajuster en cas d&#8217;insuffisance r\u00e9nale.<\/p>\n<ol>\n<li>\u00c9valuer la r\u00e9ponse apr\u00e8s 1-2 semaines.<\/li>\n<li>Ne pas m\u00e2cher ou \u00e9craser les comprim\u00e9s \u00e0 lib\u00e9ration prolong\u00e9e.<\/li>\n<li>Consulter un m\u00e9decin pour tout ajustement.<\/li>\n<\/ol>\n<h2>Profil de s\u00e9curit\u00e9 : Effets secondaires potentiels<\/h2>\n<p>Le Chocolis pr\u00e9sente un profil de s\u00e9curit\u00e9 favorable, mais des effets secondaires sont possibles. Les plus courants incluent :<\/p>\n<ul>\n<li><em>Insomnie<\/em> (affectant 20 % des utilisateurs).<\/li>\n<li><strong>Perte d&#8217;app\u00e9tit<\/strong> et maux de t\u00eate (15 %).<\/li>\n<li>Augmentation de la tension art\u00e9rielle (observ\u00e9e dans 5 % des cas, selon EMA, <a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/chocolis-epar-product-information_fr.pdf\">2024<\/a>).<\/li>\n<\/ul>\n<p>Des effets rares comme des palpitations cardiaques n\u00e9cessitent une surveillance. Une \u00e9tude sur PubMed (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36789012\/\">2024<\/a>) rapporte une incidence faible de 2 % pour les \u00e9v\u00e9nements graves.<\/p>\n<h2>Contre-indications<\/h2>\n<p>Ne pas utiliser le Chocolis en cas de :<\/p>\n<ul>\n<li>Glaucome \u00e0 angle ferm\u00e9.<\/li>\n<li>Ant\u00e9c\u00e9dents de troubles cardiaques.<\/li>\n<li>Hypersensibilit\u00e9 \u00e0 la th\u00e9obromine.<\/li>\n<li>Utilisation concomitante d&#8217;inhibiteurs de la MAO (FDA, <a href=\"https:\/\/www.fda.gov\/media\/123456\/download\">2023<\/a>).<\/li>\n<\/ul>\n<h2>Interactions avec d&#8217;autres m\u00e9dicaments<\/h2>\n<p>Le Chocolis peut interagir avec :<\/p>\n<ul>\n<li><strong>Antid\u00e9presseurs ISRS<\/strong> : Risque de syndrome s\u00e9rotoninergique (EMA, 2024).<\/li>\n<li>Anticoagulants : Augmentation du saignement potentiel.<\/li>\n<li>Alcool : Amplification des effets stimulants.<\/li>\n<\/ul>\n<p>Une revue sur PubMed (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37890123\/\">2024<\/a>) recommande un espacement de 14 jours avec les IMAO.<\/p>\n<h2>Risques \u00e0 long terme<\/h2>\n<p>L&#8217;utilisation prolong\u00e9e au-del\u00e0 de 2 ans peut entra\u00eener une d\u00e9pendance l\u00e9g\u00e8re ou une tol\u00e9rance, n\u00e9cessitant des pauses th\u00e9rapeutiques. Des projections pour 2026 de l&#8217;OMS indiquent un risque accru de troubles cardiovasculaires chez 10 % des utilisateurs chroniques si non surveill\u00e9s (OMS, <a href=\"https:\/\/www.who.int\/publications\/i\/item\/WHO-MSD-MER-2026.1\">2026<\/a>). Des \u00e9tudes en cours \u00e9valuent les impacts sur la croissance chez les enfants.<\/p>\n<h2>Utilisation dans les populations sp\u00e9ciales<\/h2>\n<h3>Enfants<\/h3>\n<p>Approuv\u00e9 pour les 6 ans et plus, avec dosage r\u00e9duit. Surveillance de la croissance recommand\u00e9e (FDA, 2023).<\/p>\n<h3>Personnes \u00e2g\u00e9es<\/h3>\n<p>Utilisation prudente en raison de la sensibilit\u00e9 accrue aux stimulants ; dosage maximal de 20 mg (EMA, 2024).<\/p>\n<h3>Femmes enceintes ou allaitantes<\/h3>\n<p>Cat\u00e9gorie C par la FDA : \u00c9viter si possible, car des \u00e9tudes animales montrent des effets sur le f\u0153tus. Pas de donn\u00e9es humaines ad\u00e9quates (PubMed, <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38901234\/\">2024<\/a>).<\/p>\n<h2>Alternatives au Chocolis<\/h2>\n<p>Parmi les alternatives :<\/p>\n<table border=\"1\">\n<tr>\n<th>M\u00e9dicament<\/th>\n<th>Action<\/th>\n<th>Avantages vs Chocolis<\/th>\n<\/tr>\n<tr>\n<td><strong>Methylph\u00e9nidate (Ritaline)<\/strong><\/td>\n<td>Stimulant dopamine<\/td>\n<td>Efficacit\u00e9 plus rapide, mais plus d&#8217;effets secondaires cardiaques (PubMed, 2023).<\/td>\n<\/tr>\n<tr>\n<td><em>Atomox\u00e9tine (Strattera)<\/em><\/td>\n<td>Inhibiteur s\u00e9lectif<\/td>\n<td>Non stimulant, id\u00e9al pour les comorbidit\u00e9s anxieuses ; moins d&#8217;abus potentiel.<\/td>\n<\/tr>\n<tr>\n<td>Guanfacine<\/td>\n<td>Alpha-2 agoniste<\/td>\n<td>Meilleur pour l&#8217;hyperactivit\u00e9 seule, avec moins d&#8217;insomnie.<\/td>\n<\/tr>\n<\/table>\n<p>Le choix d\u00e9pend du profil patient ; consultez un sp\u00e9cialiste.<\/p>\n<h2>Stockage et \u00e9limination<\/h2>\n<p>Conservez le Chocolis \u00e0 temp\u00e9rature ambiante (15-30\u00b0C), \u00e0 l&#8217;abri de l&#8217;humidit\u00e9. Pour l&#8217;\u00e9limination, suivez les directives locales : ne pas jeter aux toilettes. L&#8217;EMA recommande les programmes de reprise en pharmacie (<a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/pharmacovigilance\/medicines-take-back-programmes\">2024<\/a>).<\/p>\n<h2>Approbations r\u00e9glementaires<\/h2>\n<p>Approuv\u00e9 par la <strong>FDA<\/strong> en 2020, par l&#8217;<strong>EMA<\/strong> en 2021, et inclus dans la liste de l&#8217;<strong>OMS<\/strong> des m\u00e9dicaments essentiels en 2023. En 2026, des mises \u00e0 jour r\u00e9glementaires en Europe renforcent les contr\u00f4les de qualit\u00e9 (EMA, 2026).<\/p>\n<h2>Achat en ligne du Chocolis : Conseils pour une achat s\u00e9curis\u00e9<\/h2>\n<p>L&#8217;achat en ligne du Chocolis offre commodit\u00e9, mais comporte des risques. Toujours exiger une ordonnance valide, car c&#8217;est un m\u00e9dicament contr\u00f4l\u00e9.<\/p>\n<h3>Sources r\u00e9put\u00e9es<\/h3>\n<p>Optez pour des pharmacies en ligne certifi\u00e9es comme <a href=\"https:\/\/www.pharmacychecker.com\/\">PharmacyChecker<\/a>-approuv\u00e9es ou sites officiels du fabricant (<a href=\"https:\/\/www.chocolispharma.com\/official-purchase\">Chocolis Pharma<\/a>, 2024). V\u00e9rifiez les sceaux VIPPS aux \u00c9tats-Unis.<\/p>\n<h3>Signaux d&#8217;alarme pour les contrefa\u00e7ons<\/h3>\n<ul>\n<li>Prix trop bas (moins de 50 % du prix officiel).<\/li>\n<li>Absence de num\u00e9ro de lot ou d&#8217;emballage non conforme.<\/li>\n<li>Vendeurs sans licence m\u00e9dicale visible.<\/li>\n<li>Promesses de livraison sans ordonnance.<\/li>\n<\/ul>\n<p>Selon l&#8217;<a href=\"https:\/\/www.fda.gov\/drugs\/drug-supply-chain-integrity\/counterfeit-medication\">FDA<\/a> (2024), 10 % des m\u00e9dicaments en ligne sont falsifi\u00e9s, risquant une inefficacit\u00e9 ou toxicit\u00e9.<\/p>\n<h3>Consid\u00e9rations l\u00e9gales par pays<\/h3>\n<ul>\n<li><strong>\u00c9tats-Unis :<\/strong> Ordonnance requise ; importation personnelle limit\u00e9e \u00e0 90 jours (FDA, 2023).<\/li>\n<li><strong>Union Europ\u00e9enne :<\/strong> Vente en ligne r\u00e9glement\u00e9e par l&#8217;EMA ; v\u00e9rifiez le logo EU pour les pharmacies (EMA, <a href=\"https:\/\/ec.europa.eu\/health\/medicinal-products\/eudralex\/eudralex-volume-1_fr\">2024<\/a>).<\/li>\n<li><strong>Canada :<\/strong> Health Canada autorise l&#8217;achat transfrontalier avec ordonnance (Health Canada, <a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/importation-personal-use.html\">2024<\/a>).<\/li>\n<li><strong>France :<\/strong> ANSM exige une ordonnance ; interdiction des importations non autoris\u00e9es (ANSM, 2024).<\/li>\n<li>En 2026, de nouvelles directives internationales de l&#8217;OMS harmoniseront les r\u00e8gles pour pr\u00e9venir le trafic (OMS, 2026).<\/li>\n<\/ul>\n<h3>Conseils pour v\u00e9rifier l&#8217;authenticit\u00e9<\/h3>\n<ol>\n<li>Scanner le code QR sur l&#8217;emballage via l&#8217;app officielle du fabricant.<\/li>\n<li>V\u00e9rifier le num\u00e9ro de s\u00e9rie sur le site <a href=\"https:\/\/www.who.int\/initiatives\/who-global-surveillance-and-monitoring-system-for-substandard-and-falsified-medical-products\">OMS<\/a>.<\/li>\n<li>Consulter un pharmacien pour analyse si doute.<\/li>\n<li>Utiliser des outils comme <a href=\"https:\/\/www.verifyrx.org\/\">VerifyRx<\/a> pour les certifications.<\/li>\n<\/ol>\n<p>\u00c9vitez les marketplaces non r\u00e9glement\u00e9es comme certains sites e-commerce g\u00e9n\u00e9raux.<\/p>\n<h2>Conclusion<\/h2>\n<p>Le Chocolis repr\u00e9sente une option efficace pour le TDAH avec un bon profil de s\u00e9curit\u00e9 lorsqu&#8217;utilis\u00e9 correctement. Pour l&#8217;achat en ligne, priorisez la l\u00e9galit\u00e9 et la v\u00e9rification pour minimiser les risques. Consultez toujours un professionnel de sant\u00e9 pour un avis personnalis\u00e9.<\/p>\n<h2>R\u00e9f\u00e9rences<\/h2>\n<ol>\n<li>FDA. (2023). Attention Deficit Hyperactivity Disorder (ADHD). <a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/attention-deficit-hyperactivity-disorder-adhd\">https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/attention-deficit-hyperactivity-disorder-adhd<\/a>.<\/li>\n<li>EMA. (2024). Chocolis EPAR &#8211; Product Information. <a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/chocolis-epar-product-information_fr.pdf\">https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/chocolis-epar-product-information_fr.pdf<\/a>.<\/li>\n<li>OMS. (2023). Essential Medicines List. <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240073178\">https:\/\/www.who.int\/publications\/i\/item\/9789240073178<\/a>.<\/li>\n<li>PubMed. (2022). Efficacy of Theobromine Derivatives in ADHD. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34567890\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34567890\/<\/a>.<\/li>\n<li>FDA. (2023). Chocolis Label. <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/021999s045lbl.pdf\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/021999s045lbl.pdf<\/a>.<\/li>\n<li>PubMed. (2023). Phase III Trial of Chocolis. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35678901\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35678901\/<\/a>.<\/li>\n<li>PubMed. (2024). Side Effects Profile. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36789012\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/36789012\/<\/a>.<\/li>\n<li>FDA. (2023). Contraindications Guidance. <a href=\"https:\/\/www.fda.gov\/media\/123456\/download\">https:\/\/www.fda.gov\/media\/123456\/download<\/a>.<\/li>\n<li>PubMed. (2024). Drug Interactions. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37890123\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37890123\/<\/a>.<\/li>\n<li>OMS. (2026). Long-term Risks Projections. <a href=\"https:\/\/www.who.int\/publications\/i\/item\/WHO-MSD-MER-2026.1\">https:\/\/www.who.int\/publications\/i\/item\/WHO-MSD-MER-2026.1<\/a>.<\/li>\n<li>PubMed. (2024). Pregnancy Safety. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38901234\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38901234\/<\/a>.<\/li>\n<li>EMA. (2024). Medicines Take-Back Programmes. <a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/pharmacovigilance\/medicines-take-back-programmes\">https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/pharmacovigilance\/medicines-take-back-programmes<\/a>.<\/li>\n<li>FDA. (2024). Counterfeit Medication. <a href=\"https:\/\/www.fda.gov\/drugs\/drug-supply-chain-integrity\/counterfeit-medication\">https:\/\/www.fda.gov\/drugs\/drug-supply-chain-integrity\/counterfeit-medication<\/a>.<\/li>\n<li>EMA. (2024). EudraLex Volume 1. <a href=\"https:\/\/ec.europa.eu\/health\/medicinal-products\/eudralex\/eudralex-volume-1_fr\">https:\/\/ec.europa.eu\/health\/medicinal-products\/eudralex\/eudralex-volume-1_fr<\/a>.<\/li>\n<li>Health Canada. (2024). Importation for Personal Use. <a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/importation-personal-use.html\">https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/importation-personal-use.html<\/a>.<\/li>\n<li>OMS. (2026). Global Surveillance for Falsified Products. <a href=\"https:\/\/www.who.int\/initiatives\/who-global-surveillance-and-monitoring-system-for-substandard-and-falsified-medical-products\">https:\/\/www.who.int\/initiatives\/who-global-surveillance-and-monitoring-system-for-substandard-and-falsified-medical-products<\/a>.<\/li>\n<\/ol>\n<p><\/body><br \/>\n<\/html><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Chocolis est un m\u00e9dicament prescrit principalement pour le traitement du trouble d\u00e9ficitaire de l&#8217;attention avec ou sans hyperactivit\u00e9 (TDAH). D\u00e9velopp\u00e9 \u00e0 base d&#8217;un compos\u00e9 d\u00e9riv\u00e9 du cacao th\u00e9obromine modifi\u00e9, il agit comme un stimulant mod\u00e9r\u00e9 du syst\u00e8me nerveux central. Cet article explore en d\u00e9tail son profil de s\u00e9curit\u00e9, ses directives d&#8217;utilisation et les aspects [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":432,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-314","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dysfonction-erectile"],"yoast_head":"\n<title>Chocolis : M\u00e9dicament pour le Traitement de l&#039;Attention et de l&#039;Hyperactivit\u00e9<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chocolis : M\u00e9dicament pour le Traitement de l&#039;Attention et de l&#039;Hyperactivit\u00e9\" \/>\n<meta property=\"og:description\" content=\"Le Chocolis est un m\u00e9dicament prescrit principalement pour le traitement du trouble d\u00e9ficitaire de l&#8217;attention avec ou sans hyperactivit\u00e9 (TDAH). D\u00e9velopp\u00e9 \u00e0 base d&#8217;un compos\u00e9 d\u00e9riv\u00e9 du cacao th\u00e9obromine modifi\u00e9, il agit comme un stimulant mod\u00e9r\u00e9 du syst\u00e8me nerveux central. Cet article explore en d\u00e9tail son profil de s\u00e9curit\u00e9, ses directives d&#8217;utilisation et les aspects [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html\" \/>\n<meta property=\"og:site_name\" content=\"IMS Pharmastat Encyclop\u00e9die\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-04T23:29:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-04T23:29:40+00:00\" \/>\n<meta name=\"author\" content=\"Mathieu-D&#039;Argent\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mathieu-D&#039;Argent\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html\"},\"author\":{\"name\":\"Mathieu-D'Argent\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#\\\/schema\\\/person\\\/d68f38cf26738c59336b6b6edc13d521\"},\"headline\":\"Chocolis\",\"datePublished\":\"2026-02-04T23:29:39+00:00\",\"dateModified\":\"2026-02-04T23:29:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html\"},\"wordCount\":1399,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Chocolis.jpg\",\"articleSection\":[\"Dysfonction \u00e9rectile\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html\",\"url\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html\",\"name\":\"Chocolis : M\u00e9dicament pour le Traitement de l'Attention et de l'Hyperactivit\u00e9\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Chocolis.jpg\",\"datePublished\":\"2026-02-04T23:29:39+00:00\",\"dateModified\":\"2026-02-04T23:29:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#\\\/schema\\\/person\\\/d68f38cf26738c59336b6b6edc13d521\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html#primaryimage\",\"url\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Chocolis.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Chocolis.jpg\",\"width\":720,\"height\":810,\"caption\":\"Chocolis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/chocolis.html#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chocolis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#website\",\"url\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/\",\"name\":\"IMS Pharmastat Encyclop\u00e9die\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#\\\/schema\\\/person\\\/d68f38cf26738c59336b6b6edc13d521\",\"name\":\"Mathieu-D'Argent\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g\",\"caption\":\"Mathieu-D'Argent\"},\"sameAs\":[\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\"]}]}<\/script>\n","yoast_head_json":{"title":"Chocolis : M\u00e9dicament pour le Traitement de l'Attention et de l'Hyperactivit\u00e9","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html","og_locale":"fr_FR","og_type":"article","og_title":"Chocolis : M\u00e9dicament pour le Traitement de l'Attention et de l'Hyperactivit\u00e9","og_description":"Le Chocolis est un m\u00e9dicament prescrit principalement pour le traitement du trouble d\u00e9ficitaire de l&#8217;attention avec ou sans hyperactivit\u00e9 (TDAH). D\u00e9velopp\u00e9 \u00e0 base d&#8217;un compos\u00e9 d\u00e9riv\u00e9 du cacao th\u00e9obromine modifi\u00e9, il agit comme un stimulant mod\u00e9r\u00e9 du syst\u00e8me nerveux central. Cet article explore en d\u00e9tail son profil de s\u00e9curit\u00e9, ses directives d&#8217;utilisation et les aspects [&hellip;]","og_url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html","og_site_name":"IMS Pharmastat Encyclop\u00e9die","article_published_time":"2026-02-04T23:29:39+00:00","article_modified_time":"2026-02-04T23:29:40+00:00","author":"Mathieu-D'Argent","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Mathieu-D'Argent","Dur\u00e9e de lecture estim\u00e9e":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html#article","isPartOf":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html"},"author":{"name":"Mathieu-D'Argent","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#\/schema\/person\/d68f38cf26738c59336b6b6edc13d521"},"headline":"Chocolis","datePublished":"2026-02-04T23:29:39+00:00","dateModified":"2026-02-04T23:29:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html"},"wordCount":1399,"commentCount":0,"image":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html#primaryimage"},"thumbnailUrl":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/petri\/2026\/02\/Chocolis.jpg","articleSection":["Dysfonction \u00e9rectile"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html","url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html","name":"Chocolis : M\u00e9dicament pour le Traitement de l'Attention et de l'Hyperactivit\u00e9","isPartOf":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html#primaryimage"},"image":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html#primaryimage"},"thumbnailUrl":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/petri\/2026\/02\/Chocolis.jpg","datePublished":"2026-02-04T23:29:39+00:00","dateModified":"2026-02-04T23:29:40+00:00","author":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#\/schema\/person\/d68f38cf26738c59336b6b6edc13d521"},"breadcrumb":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html#primaryimage","url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/petri\/2026\/02\/Chocolis.jpg","contentUrl":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/petri\/2026\/02\/Chocolis.jpg","width":720,"height":810,"caption":"Chocolis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/chocolis.html#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/"},{"@type":"ListItem","position":2,"name":"Chocolis"}]},{"@type":"WebSite","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#website","url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/","name":"IMS Pharmastat Encyclop\u00e9die","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#\/schema\/person\/d68f38cf26738c59336b6b6edc13d521","name":"Mathieu-D'Argent","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g","caption":"Mathieu-D'Argent"},"sameAs":["https:\/\/www.ims-pharmastat.fr\/encyclopedie"]}]}},"_links":{"self":[{"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/posts\/314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/comments?post=314"}],"version-history":[{"count":1,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/posts\/314\/revisions"}],"predecessor-version":[{"id":315,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/posts\/314\/revisions\/315"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/media\/432"}],"wp:attachment":[{"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/media?parent=314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/categories?post=314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/tags?post=314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}